The introduction of dopamine agonists for treating tetrahydrobiopterin deficiency imposes the evaluation of peripheral prolactin as the sole reliable biochemical marker of dopaminergic homeostasis. Here we provide the clinical interpretation of the previously described short prolactin profile, based on the longitudinal monitoring of 8 patients with tetrahydrobiopterin deficiency.
Target Prolactin Range in Treatment of Tetrahydrobiopterin Deficiency
PORTA, FRANCESCO;PONZONE, Alberto;SPADA, MARCO
2016-01-01
Abstract
The introduction of dopamine agonists for treating tetrahydrobiopterin deficiency imposes the evaluation of peripheral prolactin as the sole reliable biochemical marker of dopaminergic homeostasis. Here we provide the clinical interpretation of the previously described short prolactin profile, based on the longitudinal monitoring of 8 patients with tetrahydrobiopterin deficiency.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Target Prolactin Range in Treatment of Tetrahydrobiopterin Deficiency. J Pediatr. 2016.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
279.43 kB
Formato
Adobe PDF
|
279.43 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
